Abstract
The drug discovery process in general is a very resource intensive undertaking that has existed for a very long time. In the last two decades, performing molecular simulations that determine the level of interaction between a protein and ligand have been refined to the point where they are now an essential part of the drug discovery process. These simulations serve to reduce the time to discovery and improve the positive “hit” rates when screening for molecule with biological activity. As a result, the chemical search space is greatly reduced in silico, prior to any in vitro experiments that validate the results. Recently, there have been many advances in computer science technologies that have improved the virtual screening process. This paper will give a brief overview of the virtual screening process and then summarize the current state-of-the-art technologies applied to virtual screenings. Both biomedical researchers and computer scientists can use this review as a guide to the implementation requirements for computational resources of virtual screening.
Keywords: Drug discovery, virtual screening, grid computing, cloud computing, parallel processing, virtualization, map reduce.
Current Pharmaceutical Design
Title:Virtual Screening Techniques and Current Computational Infrastructures
Volume: 22 Issue: 23
Author(s): Jason H. Haga, Kohei Ichikawa and Susumu Date
Affiliation:
Keywords: Drug discovery, virtual screening, grid computing, cloud computing, parallel processing, virtualization, map reduce.
Abstract: The drug discovery process in general is a very resource intensive undertaking that has existed for a very long time. In the last two decades, performing molecular simulations that determine the level of interaction between a protein and ligand have been refined to the point where they are now an essential part of the drug discovery process. These simulations serve to reduce the time to discovery and improve the positive “hit” rates when screening for molecule with biological activity. As a result, the chemical search space is greatly reduced in silico, prior to any in vitro experiments that validate the results. Recently, there have been many advances in computer science technologies that have improved the virtual screening process. This paper will give a brief overview of the virtual screening process and then summarize the current state-of-the-art technologies applied to virtual screenings. Both biomedical researchers and computer scientists can use this review as a guide to the implementation requirements for computational resources of virtual screening.
Export Options
About this article
Cite this article as:
H. Haga Jason, Ichikawa Kohei and Date Susumu, Virtual Screening Techniques and Current Computational Infrastructures, Current Pharmaceutical Design 2016; 22 (23) . https://dx.doi.org/10.2174/1381612822666160414142530
DOI https://dx.doi.org/10.2174/1381612822666160414142530 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature
Current Pharmaceutical Design The Role of Streptokinase as a Virulence Determinant of Streptococcus pyogenes – Potential for Therapeutic Targeting
Current Drug Targets Synthesis of Cross-linkable 2,5-Diketopiperazine Derivatives
Letters in Organic Chemistry Toll-Like Receptors, Cytokines and the Immunotherapeutics of Asthma
Current Pharmaceutical Design Interactions of Phenothiazines with Lipid Bilayer and their Role in Multidrug Resistance Reversal
Current Drug Targets Nanotechnology-Based Approaches for Combating Tuberculosis: A Review
Current Nanomaterials Antimycobacterial Profile of 5-phenyl-1,3,4-thiadiazole-2-arylhydrazone Derivatives
Letters in Drug Design & Discovery Preface [Hot Topic: Antimycobacterial Drugs: Current Status and Future Prospects (Executive Editor: Haruaki Tomioka)]
Current Pharmaceutical Design Design, Synthesis and Evaluation of Thiourea Derivatives as Antimicrobial and Antiviral Agents
Letters in Drug Design & Discovery Inhalation Delivery of Protein Therapeutics
Inflammation & Allergy - Drug Targets (Discontinued) Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Coumarine Analogues with Antimycobacterial and Immunomodulatory Activity
Current Bioactive Compounds Patent Selections
Recent Patents on Biotechnology Recent Developments in Antitubercular Drugs
Mini-Reviews in Medicinal Chemistry Anti Tumor Necrosis Factor Alpha (TNFα) Therapy in Ankylosing Spondylitis - Asian Perspective
Current Rheumatology Reviews Application of Poloxamers for the Development of Drug Delivery System to Treat Leishmaniasis: A Review
Current Drug Targets A Review of the Treatment of Psoriasis with Infliximab
Reviews on Recent Clinical Trials The β-Carbonic Anhydrases from Mycobacterium tuberculosis as Drug Targets
Current Pharmaceutical Design Structure-Based Hybridization, Conventional and Microwave Irradiated Synthesis, Biological Evaluation and Molecular Docking Studies of New Compounds Derived from Thiomorpholin
Letters in Drug Design & Discovery Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Current Pharmaceutical Biotechnology